Circulating plasma miR222-3P status and its potential diagnostic performance in prostate cancer.

Zohreh HeydariEmadoddin MoudiFarzin SadeghiMahmoud HajiahmadiSetareh RezatabarNahid NeamatiHadi Parsian

Published in: The journal of gene medicine (2022)

Circulating plasma miR-222-3p significantly upregulated in PC patients, but not in BPH ones. Besides these preliminary results showed that miR222-3p has the potential to discriminate PC patients from healthy ones. Addittional studies with a larger sample size are required to confirm these data.

Keyphrases

prostate cancer
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
machine learning
artificial intelligence